Aller au contenu principal
Fermer
  2. Aide
  2. Aide

Sartorius Stedim Biotech publie fiche factuelle T1 2026
information fournie par Reuters 23/04/2026 à 07:10

* Sartorius Stedim Biotech a publié fiche factuelle « IR Factsheet Q1 2026 ». * Chiffre d’affaires T1 2026: 761,5 millions €; variation: +7,9%. * EBITDA sous-jacent T1 2026: 233,4 millions €; marge: 30,7%. * Résultat net sous-jacent après intérêts minoritaires T1 2026: 113,6 millions €; BPA sous-jacent: 1,17 €. * Objectifs 2026: croissance du chiffre d’affaires ~6% à ~10% à change constant; marge d’EBITDA sous-jacent légèrement au-dessus de 31%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sartorius Stedim Biotech SA published the original content used to generate this news brief on April 23, 2026, and is solely responsible for the information contained therein.

(C) Copyright 2026 - Public Technologies (PUBT) Original Document: https://docs.publicnow.com/DE54E2B26BAEBC6DC43AD1E88CFFAAB9341E508D

Valeurs associées

SARTORIUS STEDIM BIOTECH
175,3000 EUR Euronext Paris -4,73%
© 2026 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.
Chargement...

Pages les plus populaires

L'offre BoursoBank